Open AccessAntithrombotic Therapy in Atrial Fibrillation and Chronic Ischemic Heart Disease
Author(s) -
А. Ю. Рычков,
N. Yu. Khorkova
Publication year - 2019
Publication title -
kardiologiâ
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.159
H-Index - 16
eISSN - 2412-5660
pISSN - 0022-9040
DOI - 10.18087/cardio.2019.5.n493
Subject(s) - antithrombotic , medicine , atrial fibrillation , cardiology , observational study , medical prescription , percutaneous coronary intervention , disease , intensive care medicine , myocardial infarction , pharmacology
The review is devoted to the use of antithrombotic therapy in patients with atrial fibrillation (AF) and chronic ischemic heart disease (IHD). We discuss data of international registries, meta-analyses assessing possibilities of the use of oral anticoagulants for secondary prevention of IHD. We present here results of randomized and observational clinical studies demonstrating advantages of prescription of monotherapy with oral anticoagulants (OAC) in combination of AF and chronic IHD. Modern evidence base of advantages of dual antithrombotic therapy with the use of direct OAC following percutaneous coronary intervention is also presented.